tigecycline (Tygacil) for community-acquired pneumonia (CAP)

May 2009

Reps will be promoting tigecycline (Tygacil) for community-acquired pneumonia (CAP).

It's now approved for this use in hospitalized patients who aren't in the ICU...but it's usually not the best choice.

The usual empiric therapy for these patients is monotherapy with levofloxacin or moxifloxacin...or a combination of a beta-lactam plus macrolide.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote